It is well known that in the pathology of Alzheimer’s disease, there is a condition of generalized and progressive inflammation during its evolution, both occurring in the brain system, then endothelial cells expressing CX3CL1 and its receptor CX3CR1. This evidence concerns the gene CX3CR1 and Alzheimer disease.